CP, you still think there's anything great coming about the liver data? Seems like a long road ahead unless Yopp mentions something along the lines of Hep C patients showing no signs of virus after follow up. Even ROTH stated a phase 2b would be the next step...not even a registrational trial.
You misread..I did not say PPHM has a grip on our throat. I'm refering to a third party..The Family a hedge fund a BP etc.keeping pressure on the price. Regards
News 
Market Data 
Discover 
